chr10-87932974-G-GT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: PTEN c.254-30dup (IVS4-30dup) meets criteria to be classified as benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).BA1: Allele frequency of 0.01437 (1.437%, 3748/260,738 alleles) in the gnomAD cohort. (PMID 27535533) LINK:https://erepo.genome.network/evrepo/ui/classification/CA146028/MONDO:0017623/003

Frequency

Genomes: 𝑓 0.010 ( 19 hom., cov: 32)
Exomes 𝑓: 0.014 ( 112 hom. )

Consequence

PTEN
NM_000314.8 intron

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel U:1B:5

Conservation

PhyloP100: 1.19

Publications

1 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
NM_000314.8
MANE Select
c.254-30dupT
intron
N/ANP_000305.3
PTEN
NM_001304717.5
c.773-30dupT
intron
N/ANP_001291646.4
PTEN
NM_001304718.2
c.-497-30dupT
intron
N/ANP_001291647.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
ENST00000371953.8
TSL:1 MANE Select
c.254-39_254-38insT
intron
N/AENSP00000361021.3
PTEN
ENST00000693560.1
c.773-39_773-38insT
intron
N/AENSP00000509861.1
PTEN
ENST00000700029.2
c.254-39_254-38insT
intron
N/AENSP00000514759.2

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1571
AN:
151410
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00192
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00994
Gnomad ASJ
AF:
0.0344
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0137
Gnomad FIN
AF:
0.0162
Gnomad MID
AF:
0.0287
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.0155
GnomAD2 exomes
AF:
0.0147
AC:
3371
AN:
229604
AF XY:
0.0159
show subpopulations
Gnomad AFR exome
AF:
0.00173
Gnomad AMR exome
AF:
0.0105
Gnomad ASJ exome
AF:
0.0385
Gnomad EAS exome
AF:
0.000118
Gnomad FIN exome
AF:
0.0216
Gnomad NFE exome
AF:
0.0157
Gnomad OTH exome
AF:
0.0180
GnomAD4 exome
AF:
0.0137
AC:
17934
AN:
1311240
Hom.:
112
Cov.:
23
AF XY:
0.0140
AC XY:
9255
AN XY:
659250
show subpopulations
African (AFR)
AF:
0.00315
AC:
95
AN:
30204
American (AMR)
AF:
0.0104
AC:
457
AN:
43894
Ashkenazi Jewish (ASJ)
AF:
0.0350
AC:
873
AN:
24964
East Asian (EAS)
AF:
0.000494
AC:
19
AN:
38486
South Asian (SAS)
AF:
0.0173
AC:
1427
AN:
82304
European-Finnish (FIN)
AF:
0.0200
AC:
1040
AN:
52070
Middle Eastern (MID)
AF:
0.0351
AC:
192
AN:
5470
European-Non Finnish (NFE)
AF:
0.0133
AC:
13005
AN:
978634
Other (OTH)
AF:
0.0150
AC:
826
AN:
55214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
717
1434
2150
2867
3584
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0104
AC:
1570
AN:
151528
Hom.:
19
Cov.:
32
AF XY:
0.00997
AC XY:
739
AN XY:
74088
show subpopulations
African (AFR)
AF:
0.00191
AC:
79
AN:
41346
American (AMR)
AF:
0.00993
AC:
151
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.0344
AC:
119
AN:
3460
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.0140
AC:
67
AN:
4800
European-Finnish (FIN)
AF:
0.0162
AC:
170
AN:
10486
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.0139
AC:
944
AN:
67754
Other (OTH)
AF:
0.0148
AC:
31
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
72
144
217
289
361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
1
Bravo
AF:
0.00991

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
1
-
Cowden syndrome 1 (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
PTEN hamartoma tumor syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77494260; hg19: chr10-89692731; COSMIC: COSV100909132; API